Dr Shaji’s Comprehensive Dementia Protocol with Plasma Biomarkers & Functional MRI
Dr. Shaji’s MRI is proud to introduce the region’s most advanced dementia protocol pTau 217 and β- Amyloid 1-42 Ratio along with functional MRI study. This is more than a milestone: it’s a step towards early detection, timely intervention, and hope for Alzheimer’s patients.
The Hidden Challenges Of Current Diagnosis
In the past, diagnosing Alzheimer’s disease and other forms of dementia relied on a few key methods, but each had serious limitations:
The Current Industry Standard:
Clinical History & Assessment: Relying on memory tests and family input. This is often subjective and can delay diagnosis until the disease is in an advanced stage.
Brain Imaging (MRI/CT): Used to check for physical issues like strokes or tumors. However, a standard MRI alone is not accurate enough to confirm early AD.
CSF Biomarkers: A highly accurate test, but it requires a painful, invasive lumbar puncture (spinal tap), leading to low patient acceptance.
Specialized PET Scans: Powerful, but are extremely expensive, require radiation, and have limited availability.
Specialized PET Scans: Powerful, but are extremely expensive, require radiation, and have limited availability.
